why choose us

300×250 Ad Slot

Drug FDA Status

Showing 172 of 172 result(s) (Page 18 of 18)
Drug Name: Brenzavvy

Active Ingredient: bexagliflozin

Approval Date: 2023-01-20

Description: To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise
Drug Trials Snapshot

Drug Name: Leqembi

Active Ingredient: lecanemab-irmb

Approval Date: 2023-01-06

Description: To treat Alzheimer's disease
Press Release

300×250 Ad Slot